Regulatory PathRegulatory requirements compared

Active substances

Insulin nph + Regular

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
HUMULIN 70/30 100IU/ml CARTRIDGE70, 30 IU/mlSuspension for injection · Subcutaneous use5 CartridgeSAR 93.70Biological · PrescriptionEli Lilly and CompanyWithdrawn by MAH · Not Marketed
HUMULIN PROFILE80-20100IU-ML CARTRIDGE80, 20 IU/mlSolution for injection · Subcutaneous use5 CartridgeSAR 93.70Biological · OTCEli Lilly and CompanyWithdrawn by MAH · Not Marketed
MIXTARD 10 NOVO LET ,100 IU90, 10 IU/mlSolution for injection · Subcutaneous use5 CartridgeSAR 157.80Biological · PrescriptionNOVO NORDISKWithdrawn by MAH · Not Marketed
MIXTARD 10-90U-ML HM PENFILL CARTRIG 3ML90, 10 IU/mlSolution for injection in cartridge · Subcutaneous use5 CartridgeSAR 103.35Biological · PrescriptionNOVO NORDISKWithdrawn by MAH · Not Marketed
MIXTARD 20 NOVO LET , 100IU80, 20 IU/mlSuspension for injection · Subcutaneous use5 CartridgeSAR 157.80Biological · PrescriptionNOVO NORDISKWithdrawn by MAH · Not Marketed
MIXTARD 20 PENFILL 100 IU-ML CARTRIDGE80, 20 IU/mlSolution for injection in cartridge · Subcutaneous use5 CartridgeSAR 103.35Biological · PrescriptionNOVO NORDISKWithdrawn by MAH · Not Marketed
MIXTARD 30 HM 100 IU PENFILL70, 30 IU/mlSolution for injection in cartridge · Subcutaneous use5 CartridgeSAR 62.65Biological · PrescriptionNOVO NORDISKWithdrawn by MAH · Not Marketed
MIXTARD 30 NOVOLET 100I.U.70, 30 IU/mlSuspension for injection · Subcutaneous use5 CartridgeSAR 166.35Biological · PrescriptionNOVO NORDISKWithdrawn by MAH · Not Marketed
MIXTARD 40 NOVO LET ,100IU60, 40 IU/mlSuspension · Subcutaneous use5 CartridgeSAR 157.80Biological · PrescriptionNOVO NORDISKWithdrawn by MAH · Not Marketed
MIXTARD 40 PENFILL60, 40 IU/mlSuspension for injection · Subcutaneous use5 CartridgeSAR 103.35Biological · PrescriptionNOVO NORDISKWithdrawn by MAH · Not Marketed
MIXTARD 50 HM NOVOLET50, 50 IU/mlSuspension · Subcutaneous use5 CartridgeSAR 157.80Biological · PrescriptionNOVO NORDISKWithdrawn by MAH · Not Marketed

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.